Mifepristone and misoprostol

DRUG5 trials

Sponsors

University of Pittsburgh, Boston University, Gynuity Health Projects, Harran University

Conditions

Abortion SeekersAbortion, SpontaneousAnembryonic PregnancyEarly Pregnancy FailureEarly Pregnancy LossFetal DemiseMedical AbortionMenstrual Regulation

Phase 4

Mifepristone at Same Time Multicenter Study

CompletedNCT00269568

University of PittsburghAbortion Seekers

Start: 2004-06-30End: 2006-04-30Updated: 2016-01-29

The Extended Gestational Age Medical Abortion Study

CompletedNCT00997347

Gynuity Health ProjectsMedical Abortion

Start: 2009-07-31End: 2012-02-29Updated: 2012-07-02

Introducing Mifepristone-Misoprostol for Menstrual Regulation in Public Sector Facilities in Bangladesh

CompletedNCT01798017

Gynuity Health ProjectsMenstrual Regulation

Start: 2012-11-30End: 2015-08-31Updated: 2015-12-10

Unknown Phase

MiMi: A Randomized Trial of Mifepristone and Misoprostol for Treatment of Early Pregnancy Failure

TerminatedNCT00468299

Boston UniversityAnembryonic Pregnancy, Early Pregnancy Failure, Fetal Demise +1

Start: 2007-04-30End: 2008-12-31Updated: 2011-07-21

Surgical vs. Medical Abortion on Sexual Function After Early Pregnancy Loss

CompletedNCT07646275

Harran UniversityAbortion, Spontaneous, Early Pregnancy Loss, Miscarriage +1

Start: 2025-04-01End: 2026-01-31Updated: 2026-06-12

Related Papers

Mifepristone–misoprostol for menstrual regulation in public sector facilities in Bangladesh

International Journal of Gynecology & Obstetrics2017-10-194 citations

Extending outpatient medical abortion services through 70 days of gestational age.

2012-11-0173 citations

Mifepristone and misoprostol administered simultaneously versus 24 hours apart for abortion: a randomized controlled trial.

2007-04-0179 citations